Jacob J. Plattner

7.9k total citations · 1 hit paper
113 papers, 4.8k citations indexed

About

Jacob J. Plattner is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Jacob J. Plattner has authored 113 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 49 papers in Organic Chemistry and 35 papers in Infectious Diseases. Recurrent topics in Jacob J. Plattner's work include HIV/AIDS drug development and treatment (23 papers), Cancer therapeutics and mechanisms (14 papers) and Chemical Synthesis and Analysis (13 papers). Jacob J. Plattner is often cited by papers focused on HIV/AIDS drug development and treatment (23 papers), Cancer therapeutics and mechanisms (14 papers) and Chemical Synthesis and Analysis (13 papers). Jacob J. Plattner collaborates with scholars based in United States, China and United Kingdom. Jacob J. Plattner's co-authors include Stephen J. Baker, Tsutomu Akama, Daniel T. W. Chu, Vincent Hernandez, Huchen Zhou, M.R. Alley, Leonard Katz, Henry Rapoport, Daniel W. Norbeck and Dale J. Kempf and has published in prestigious journals such as Science, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

Jacob J. Plattner

112 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

2007 502 citations Fernando Rock, Weimin Mao et al. Science profile →

Peers

Countries citing papers authored by Jacob J. Plattner

Since Specialization

Citations

This map shows the geographic impact of Jacob J. Plattner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob J. Plattner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob J. Plattner more than expected).

Fields of papers citing papers by Jacob J. Plattner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob J. Plattner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob J. Plattner. The network helps show where Jacob J. Plattner may publish in the future.

Co-authorship network of co-authors of Jacob J. Plattner

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob J. Plattner. A scholar is included among the top collaborators of Jacob J. Plattner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob J. Plattner. Jacob J. Plattner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis 2020 ·PLoS neglected tropical diseases ·Alexandra Ehrens, Christopher S. Lunde, Robert T. Jacobs, (unknown), Marianne Koschel, Stefan J. Frohberger, (unknown), (unknown), Joseph D. Turner, Stephen A. Ward, Mark J. Taylor, Yvonne R. Freund, Rianna Stefanakis, Eric E. Easom, Xianfeng Li, Jacob J. Plattner, Achim Hoerauf, Marc P. Hübner	12
2	Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis 2019 ·Nature Communications ·Christopher S. Lunde, Erin E. Stebbins, Rajiv S. Jumani, Mahmudul Hasan, Peter G. Miller, John Barlow, Yvonne R. Freund, Pamela Berry, Rianna Stefanakis, Jiří Gut, Philip J. Rosenthal, Melissa S. Love, Case W. McNamara, Eric E. Easom, Jacob J. Plattner, Robert T. Jacobs, Christopher D. Huston	44
3	Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate 2017 ·Journal of Medicinal Chemistry ·Yong-Kang Zhang, Jacob J. Plattner, Eric E. Easom, Robert T. Jacobs, (unknown), Yvonne R. Freund, Pamela Berry, Vic Ciaravino, John C. L. Erve, Philip J. Rosenthal, Brice Campo, Francisco‐Javier Gamo, Laura M. Sanz, Jianxin Cao	53
4	Discovery of novel P3-oxo inhibitor of hepatitis C virus NS3/4A serine protease 2012 ·Bioorganic & Medicinal Chemistry Letters ·Maosheng Duan, Wieslaw M. Kazmierski, Renae M. Crosby, Margaret Gartland, (unknown), (unknown), Amy Wang, Robert Hamatake, Lois L. Wright, Min Wu, Yong-Kang Zhang, Charles Z. Ding, Xianfeng Li, Yang Liu, Suoming Zhang, Yasheen Zhou, Jacob J. Plattner, Stephen J. Baker	1
5	Design, Synthesis, and Structure−Activity Relationship of Trypanosoma brucei Leucyl-tRNA Synthetase Inhibitors as Antitrypanosomal Agents 2011 ·Journal of Medicinal Chemistry ·Dazhong Ding, (unknown), (unknown), Yaxue Zhao, Qing Wang, Bakela Nare, Robert T. Jacobs, Fernando Rock, (unknown), Jacob J. Plattner, Guoqiang Chen, Dawei Li, Huchen Zhou	71
6	Synthesis and SAR of novel benzoxaboroles as a new class of β-lactamase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Yi Xia, (unknown), Yasheen Zhou, M.R. Alley, Fernando Rock, Manisha Mohan, Maliwan Meewan, Stephen J. Baker, (unknown), Charles Z. Ding, (unknown), (unknown), Jacob J. Plattner	65
7	Novel Semisynthetic Derivative of Antibiotic Eremomycin Active against Drug-Resistant Gram-Positive Pathogens Including Bacillus anthracis 2007 ·Journal of Medicinal Chemistry ·Kirk R. Maples, Conrad R. Wheeler, (unknown), Jacob J. Plattner, Daniel I. Chu, Yongkang Zhang, M. N. Preobrazhenskaya, Svetlana S. Printsevskaya, Svetlana E. Solovieva, Eugenia N. Olsufyeva, Henry S. Heine, Julie A. Lovchik, C. Richard Lyons	21
8	An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site breakdown → 2007 ·Science ·Fernando Rock, Weimin Mao, A. Yaremchuk, M. A. Tukalo, Thibaut Crépin, Huchen Zhou, (unknown), Vincent Hernandez, Tsutomu Akama, Stephen J. Baker, Jacob J. Plattner, Lucy Shapiro, Susan A. Martinis, Stephen J. Benkovic, S. Cusack, M.R. Alley	502
9	Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases 2006 ·Bioorganic & Medicinal Chemistry Letters ·Stephen J. Baker, Tsutomu Akama, (unknown), (unknown), (unknown), Rajeshwar Singh, (unknown), Jehangir Khan, Jacob J. Plattner, Stephen J. Benkovic, (unknown), Kirk R. Maples	68
10	Synthesis and antibacterial activity of C12 des-methyl ketolides 2006 ·Bioorganic & Medicinal Chemistry Letters ·Xiaodong Lin, (unknown), Daniel T. W. Chu, Georgia Law Carroll, (unknown), Ribhi M. Shawar, Manoj C. Desai, Jacob J. Plattner	8
11	Discovery, SAR, synthesis, pharmacokinetic and biochemical characterization of A-192411: A novel fungicidal lipopeptide-(I) 2003 ·Bioorganic & Medicinal Chemistry Letters ·Weibo Wang, Qun Li, Lisa Hasvold, (unknown), Daniel A. Dickman, Hong Ding, (unknown), Hui-Ju Chen, David J. Frost, Robert C. Goldman, Kennan C. Marsh, Yu‐Hua Hui, Brian J. Cox, Angela M. Nilius, (unknown), Paul A. Lartey, Jacob J. Plattner, Youssef L. Bennani	8
12	Synthesis and structure–activity relationships of a novel series of HIV-1 protease inhibitors encompassing ABT-378 (Lopinavir) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Hing L. Sham, David A. Betebenner, Xiaoqi Chen, Ayda Saldivar, Sudthida Vasavanonda, Dale J. Kempf, Jacob J. Plattner, Daniel W. Norbeck	14
13	Antifungal rapamycin analogues with reduced immunosuppressive activity 2000 ·Bioorganic & Medicinal Chemistry Letters ·Daniel A. Dickman, Hong Ding, Qun Li, Angela M. Nilius, (unknown), Stephen J. Ballaron, James M. Trevillyan, Morey L. Smith, (unknown), Ki H. Kim, Aparna V. Sarthy, Robert C. Goldman, Jacob J. Plattner, Youssef L. Bennani	14
14	Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus 1998 ·Virology ·Akhteruzzaman Molla, Sudthida Vasavanonda, Gondi Kumar, Hing L. Sham, (unknown), Brian Grabowski, Jon F. Denissen, William E. Kohlbrenner, Jacob J. Plattner, John M. Leonard, Daniel W. Norbeck, Dale J. Kempf	154
15	Pseudo‐symmetrical difluoroketones 1993 ·FEBS Letters ·Hing L. Sham, David A. Betebenner, Norman E. Wideburg, Ayda Saldivar, William E. Kohlbrenner, (unknown), Sudthida Vasavanonda, Dale J. Kempf, Jacob J. Clement, John E. Erickson, Jacob J. Plattner, Daniel W. Norbeck	12
16	Nonpeptide renin inhibitors employing a novel 3-aza (or oxa)-2,4-dialkyl glutaric acid moiety as a P2/P3 amide bond replacement 1992 ·Journal of Medicinal Chemistry ·William R. Baker, Anthony K. L. Fung, Hollis D. Kleinert, Herman H. Stein, Jacob J. Plattner, (unknown), (unknown), Jerome Cohen, David A. Egan	12
17	Synthesis and activity of C-21 alkylamino derivatives of (9R)-erythromycylamine. 1992 ·The Journal of Antibiotics ·Paul A. Lartey, Shari L. DeNinno, Ramin Faghih, Dwight J. Hardy, Jacob J. Clement, Jacob J. Plattner	10
18	Potent HIV-1 protease inhibitors with antiviral activities in vitro 1991 ·Biochemical and Biophysical Research Communications ·Hing L. Sham, David A. Betebenner, Norman E. Wideburg, Ayda Saldivar, William E. Kohlbrenner, Sudthida Vasavanonda, Dale J. Kempf, Daniel W. Norbeck, Chen Zhao, Jacob J. Clement, John E. Erickson, Jacob J. Plattner	17
19	Renin inhibitors. Dipeptide analogs of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability 1988 ·Journal of Medicinal Chemistry ·Jacob J. Plattner, Patrick A. Marcotte, Hollis D. Kleinert, Herman H. Stein, Jonathan Greer, Giorgio Bolis, Anthony K. L. Fung, Barbara A. Bopp, Jay R. Luly	54
20	Renin inhibitors. Design and synthesis of a new class of conformationally restricted analogs of angiotensinogen 1988 ·Journal of Medicinal Chemistry ·Hing L. Sham, Giorgio Bolis, Herman H. Stein, Stephen W. Fesik, Patrick A. Marcotte, Jacob J. Plattner, (unknown), Jonathan Greer	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact